“Allergic people excluded from phase 3”

Published on: 12/18/2020 1:30 PM

Participants “in our” Phase 3 Covid vaccine study “were excluded if they had a history of a severe vaccine-associated adverse reaction or a severe allergic reaction (eg, anaphylaxis) to any component of the experimental vaccine.” Pfizer told Adnkronos Health, following the cases of allergic reaction in some vaccinated subjects in Britain and Alaska.

“Overall, no signs of safety concern were identified in our clinical trials, including no signs of severe allergic reactions associated with the vaccine,” notes the pharmaceutical company that developed the anti-Covid serum in conjunction with BionTech.